
PharmEasy’s Valuation Plummets 92% Amidst Market Downturn
The valuation of PharmEasy’s parent, API Holdings, has taken a serious beating. From being valued at $5.6 billion, it came down to $458 million, which is a drop of 92%. It was due to a number of factors, including some really unfavorable market conditions and investor concern. Janus Henderson, one of PharmEasy’s investors, cut the…